References
- Andersen T, Hvid M, Johansen C, Stengaard-Pedersen K, Hetland ML, Horslev-Petersen K, et al. Interleukin-23 in early disease development in rheumatoid arthritis. Scand J Rheumatol. 2015, 19:1-5.
- Arend WP. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum. 2001, 45:101-106. https://doi.org/10.1002/1529-0131(200102)45:1<101::AID-ANR90>3.0.CO;2-7
- Attur M, Krasnokutsky-Samuels S, Samuels J, Abramson SB. Prognostic biomarkers in osteoarthritis. Current Opinion in Rheumatology. 2013, 25:136-144. https://doi.org/10.1097/BOR.0b013e32835a9381
- Badolato R, Oppenheim JJ. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum. 1996, 26:526-538. https://doi.org/10.1016/S0049-0172(96)80041-2
- Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008, 118:3537-3545. https://doi.org/10.1172/JCI36389
- Castro-Santos P, Laborde CM, Diaz-Pena R. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers. Clin Exp Rheumatol. 2015, 33:279-286.
- Cauwels A, Rogge E, Vandendriessche B, Shiva S, Brouckaert P. Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 2014, 5:e1102. https://doi.org/10.1038/cddis.2014.70
- Chang Y, Wei W. Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin Exp Immunol. 2015, 179:137-145. https://doi.org/10.1111/cei.12467
- Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015, 17:e1887.
- Cribbs A, Feldmann M, Oppermann U. Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications. Ther Adv Musculoskelet Dis. 2015, 7:206-219. https://doi.org/10.1177/1759720X15598307
- Crowson CS, Liao KP, Davis JM, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013, 166:622-628. https://doi.org/10.1016/j.ahj.2013.07.010
- Dessein PH, Solomon A, Woodiwiss AJ, Norton GR, Tsang L, Gonzalez-Gay MA. Marked independent relationships between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis. Mediators Inflamm. 2013, 2013:510243.
- Gerlag DM, Norris JM, Tak PP. RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment. Rheumatology. 2015, pii: kev347.
- Gibson DS, Bustard MJ, McGeough CM, Murray HA, Crockard MA, McDowell A, et al. Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. Expert Rev Mol Diagn. 2015, 15:219-234. https://doi.org/10.1586/14737159.2015.969244
- Goeb V, Jouen F, Gilbert D, Le Loet X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine. 2009, 76:343-349. https://doi.org/10.1016/j.jbspin.2008.12.006
- Han BK, Olsen NJ, Bottaro A. The CD27-CD70 pathway and pathogenesis of autoimmune disease. Semin Arthritis Rheum. 2015, 15:199-207.
- Hayashi N, Kumagai S. Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis. Rinsho Byori. 2010, 58:466-479.
- Jimenez SA, Piera-Velazquez S. Potential role of human-specific genes, human-specific microRNAs and human-specific noncoding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjogren's syndrome. Autoimmun Rev. 2013, 12:1046-1051. https://doi.org/10.1016/j.autrev.2013.04.004
- Kaneko Y, Kuwana M, Kameda H, Takeuchi T. Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2011, 50(7):1268-1274. https://doi.org/10.1093/rheumatology/keq442
- Kim DA, Kim TY. Anti-microtubule organizing center with microtubule by autoimmune target test is also useful serological marker in rheumatoid arthritis evaluation. Rheumatol Int. 2013, 33:805-808. https://doi.org/10.1007/s00296-011-2228-9
- Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol. 2005, 23:1-21. https://doi.org/10.1146/annurev.immunol.23.021704.115806
- Kitagawa T, Shibasaki K, Toya S. Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjogren's syndrome. Clin Rheumatol. 2012, 31:105-112. https://doi.org/10.1007/s10067-011-1789-z
- Koller MD. Targeted therapy in rheumatoid arthritis. Wien Med Wochenschr. 2006, 156:53-60. https://doi.org/10.1007/s10354-005-0245-6
- Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005, 6:789-800. https://doi.org/10.1038/nrm1740
- Lapteva N, Ide K, Nieda M, Ando Y, Hatta-Ohashi Y, et al. Activation and suppression of reninangiotensin system in human dendritic cells. Biochem Biophys Res Commun. 2002, 296:194-200. https://doi.org/10.1016/S0006-291X(02)00855-0
- Lettieri Barbato D, Aquilano K, Baldelli S, Cannata SM, Bernardini S, Rotilio G, et al. Proline oxidase-adipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation. Cell Death Differ. 2014, 21:113-123. https://doi.org/10.1038/cdd.2013.137
- Mariani A, Marsili M, Nozzi M, Faricelli R, Chiarelli F, Breda L. Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases. Clin Exp Rheumatol. 2015, 33:109-114.
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365:2205-2219. https://doi.org/10.1056/NEJMra1004965
- Meune C, Touze E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in RA: levels of associations of myocardial infarction and stroke through a systematic review and metaanalysis. Arch Cardiovasc Dis. 2010, 103:253-261. https://doi.org/10.1016/j.acvd.2010.03.007
- Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, Ochi M, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2008, 58:1284-1292. https://doi.org/10.1002/art.23429
- Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009, 157:209-215. https://doi.org/10.1111/j.1365-2249.2009.03944.x
- Niimoto T, Nakasa T, Ishikawa M, Okuhara A, Izumi B, Deie M, et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord. 2010, 11:209. https://doi.org/10.1186/1471-2474-11-209
- Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum. 2008, 58:2686-2693. https://doi.org/10.1002/art.23758
- Nishino J, Tanaka S, Kadono Y, Matsui T, Komiya A, Nishimura K, et al. The usefulness of neutrophil CD64 expression in the diagnosis of local infection in patients with rheumatoid arthritis in daily practice. J Orthop Sci. 2010, 15:547-552. https://doi.org/10.1007/s00776-010-1498-5
- Oh JS, Park CB. Study on Seropositive Rate of Rheumatoid arthritis Test in the Medi-screeners. Korean J Clin Lab Sci. 1997, 29:35-42.
- Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006, 35:169-174. https://doi.org/10.1080/03009740600718080
- Otter SJ, Lucas K, Springett K, Moore A, Davies K, Cheek L, et al. Foot pain in rheumatoid arthritis prevalence, risk factors and management: an epidemiological study. Clin Rheumatol. 2010, 29:255-271. https://doi.org/10.1007/s10067-009-1312-y
- Park M, Pyun JC, Akter H, Nguyen BT, Kang MJ. Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide. J Pharm Biomed Anal. 2015, 115:107-113. https://doi.org/10.1016/j.jpba.2015.06.032
- Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther. 2008, 10:R101. https://doi.org/10.1186/ar2493
- Reyes-Castillo Z, Palafox-Sanchez CA, Parra-Rojas I, Martinez-Bonilla GE, Del Toro-Arreola S, Ramirez-Duenas MG, et al. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol. 2015, 182:119-131. https://doi.org/10.1111/cei.12677
- Sato H, Tanabe N, Murasawa A, Otaki Y, Sakai T, Sugaya T, et al. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis. J Rheumatol. 2012, 39:1517-1523. https://doi.org/10.3899/jrheum.111601
- Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection. 1998, 26:274-276. https://doi.org/10.1007/BF02962246
- Segurado OG, Sasso EH. Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014, 32:S-29-34.
- Shi LL, Chen P, Xun YP, Yang WK, Yang CH, Chen GY, et al. Prohibitin as a novel autoantigen in rheumatoid arthritis. Cent Eur J Immunol. 2015, 40:78-82.
- Smith EP, Shanks K, Lipsky MM, DeTolla LJ, Keegan AD, Chapoval SP. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol. 2011, 12:30. https://doi.org/10.1186/1471-2172-12-30
- Smolen JS, Alehata D, Redlich K. The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat Rev Rheumatol. 2012, 8:235-243. https://doi.org/10.1038/nrrheum.2012.23
- Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Explaining the cardiovascular risk associated with RA traditional risk factors versus markers of RA severity. Ann Rheum Dis. 2010, 69:1920-1925. https://doi.org/10.1136/ard.2009.122226
- Suzuki A, Yamamoto K. From genetics to functional insights into rheumatoid arthritis. Clin Exp Rheumatol. 2015, 33:40-43.
- Teixeira PC, Ferber P, Vuilleumier N, Cutler P. Biomarkers for cardiovascular risk assessment in autoimmune diseases. Proteomics Clin Appl. 2015, 9:48-57. https://doi.org/10.1002/prca.201400125
- Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D, Sitaraman SV. Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin a3 expression. Mol Biol Cell. 2009, 20:4412-4423. https://doi.org/10.1091/mbc.e09-05-0361
- Theiss AL, Sitaraman SV. The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta. 2011, 1813:1137-1143. https://doi.org/10.1016/j.bbamcr.2011.01.033
- Traves PG, Pardo V, Pimentel-Santillana M, Gonzalez- Rodriguez A, Mojena M, Rico D, et al. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge. Cell Death Dis. 2014, 5:e1125. https://doi.org/10.1038/cddis.2014.90
- Wang L, Song G, Zheng Y, Tan W, Pan J, Zhao Y, et al. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Arthritis Res Ther. 2015, 17:227. https://doi.org/10.1186/s13075-015-0734-y
- Yang XK, Xu WD, Leng RX, Liang Y, Liu YY, Fang XY, et al. Therapeutic potential of IL-15 in rheumatoid arthritis. Hum Immunol. 2015, 15:478-484.
- Zhang WC, Wu H, Chen WX. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis. Clin Chem Lab Med. 2014, 52(6):779-790.
-
Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, et al. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-
${\alpha}$ . Nat Med. 2012, 18:1077-1086. https://doi.org/10.1038/nm.2815 - Zordan P, Rigamonti E, Freudenberg K, Conti V, Azzoni E, Rovere-Querini P, et al. Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration. Cell Death Dis. 2014, 5:e1031. https://doi.org/10.1038/cddis.2013.558